• Overview - presents up to four clinically relevant patterns, dashboard statistics as well as the patient’s Best Day. This quick summary can help focus the discussion on problem areas contributing to hyper- and hypoglycemia. When printed, this one page summary contains all information for billing 95251* - a CPT code covered by most insurance carriers.
• Patterns - dive deeper into each of the four clinically relevant patterns. Each pattern provides graphs of the days that contribute to that pattern.
• Data - Trends and Overlay graphs show aggregate data with filtering options. Daily graphs are a detailed view of every glucose data point for each day selected.
• Compare - report provides side-by-side comparison of Trends, Overlay and Daily graphs to encourage progress and highlight challenges patients may face.
• Statistics - provides focused insight for both daily and hourly glucose metrics. Advanced metrics can be selected for deeper analytics.
• AGP - standardized Ambulatory Glucose Profile (AGP) report provides a big picture view of diabetes management.

The Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System is the latest professional CGM system created by Dexcom for healthcare providers (HCPs). Dexcom G6 Pro is factory-calibrated—zero fingersticks are required.* Dexcom G6 Pro features a one-touch auto-applicator and a single-use, disposable transmitter that auto-starts. The Dexcom G6 Pro CGM System is comprised of a sensor, transmitter, and (if used in unblinded mode) a patient’s compatible smart device.^† In unblinded mode, Dexcom G6 Pro sends glucose readings to a patient’s compatible smart device every five minutes. Dexcom G6 Pro is indicated for patients ages 2 years and older.

*If your glucose alerts and readings from Dexcom G6 Pro do not match symptoms or expectations (when used in unblinded mode), use a blood glucose meter to make diabetes treatment decisions.

†Patient must have a compatible smart phone for an unblinded mode session. To view a list of compatible devices, visit dexcom.com/compatibility

Dexcom does not currently anticipate any interruptions to our production abilities or capacities. However, we do anticipate delays in the near term related to our customer service and technical support, which means that patients should expect longer wait times on the phone. We appreciate your patients’ understanding and patience during this time.

Dexcom is still accepting orders for products and supplies at this time and does not currently anticipate any interruptions to our ability to produce and supply product, as a result of the coronavirus. However, to ensure supply continuity for all customers, we won’t be processing additional orders for supplies outside of what is covered by a patient’s insurance at this time.

At Dexcom, we consider patient safety our number one priority. With the recent news of the impact COVID-19 is having across the US, we are aligned with community actions that will prevent the spread of the virus and have made the decision to have our field-based employees work from home. We will only allow our employees to enter your facility once it is determined safe to do so. In the meantime, diabetes will continue, and we want to make sure that you have all of the information you need to treat this at-risk population successfully. Our field and all supporting partners will be available via email, telephone, and video meetings to help you meet the needs of your patients with diabetes.

No. While the State of California recently issued a stay-at-home order requiring non-essential businesses to close until further notice, the order does not apply to companies performing “essential” services or functions like Dexcom.

Yes. Remote consultations using Dexcom Clarity may still be eligible for reimbursement under billing code 95251. For resources to set up Dexcom Clarity Clinic, please click here.

*The reimbursement information provided is intended to assist you with billing for your services related to continuous glucose monitoring (CGM). It is intended for informational purposes only and is not a guarantee of coverage and payment. Providers are encouraged to contact their local payers with questions related to coverage, coding, and payment.

Yes. Dexcom apps and software will continue to operate without interruption, and the company does not anticipate any outages or delays due to the coronavirus situation. Patients may check the live status of each of our apps and software at status.dexcom.com.

Please click here for patient support and resources.

Dexcom will continue to process re-orders, but we ask that patients only contact the Customer Sales Support and Technical Support teams at 844-607-8398 with urgent requests at this time.

Answers to many common patient questions are available at dexcom.com/answers, and patients can submit web self-service tickets at dexcom.com/contact. Our team will work to expeditiously respond to those inquiries.

The Dexcom CARE team is also still available at dexcom.com/dexcom-care or 877-339-2664 to help patients that are new to Dexcom and need help getting started with their product.

Patients can continue to get their products from the pharmacy or DME providers. Several national pharmacies are offering home delivery services. Please ask your patients to contact their preferred pharmacy or DME provider for options.